<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0019">
 <label>19</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Palmieri</surname>
    <given-names>C</given-names>
   </name>, 
   <name name-style="western">
    <surname>Stein</surname>
    <given-names>RC</given-names>
   </name>, 
   <name name-style="western">
    <surname>Liu</surname>
    <given-names>X</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>A Phase II study to assess the safety and efficacy of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER positive locally advanced or metastatic breast cancer patients (IRIS) – trial results</article-title>. 
  <source>J Clin Oncol</source>
  <year>2016</year>;
  <volume>34</volume>:
  <fpage>549</fpage>.
 </mixed-citation>
</ref>
